Laos vs Libya: Antiretroviral therapy coverage for PMTCT
Laos
68.0%
in 2024
Libya
70.0%
in 2023
Laos rank
54th
Libya rank
51st
Antiretroviral therapy coverage for PMTCT over time
- Laos
- Libya
How they compare
Libya currently reports 70.0% against 68.0% in Laos, a difference of 2.0%.
The two have swapped places 2 times across 18 shared years of data; in 2000 it was Libya ahead.
Laos ranks 54th and Libya ranks 51st of 84 countries.
Across the 3 decades both report, Laos averaged higher in 1 and Libya in 2.
Head to head by decade
| Decade | Laos | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.2% | 0.0% | 4.2% | Laos |
| 2010s | 28.0% | 65.8% | 37.8% | Libya |
| 2020s | 39.0% | 71.0% | 32.0% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Laos or Libya?
- Libya, at 70.0% against 68.0% in Laos as of 2023.
- What is the difference in antiretroviral therapy coverage for pmtct between Laos and Libya?
- 2.0%, with Libya ahead.
- How many years of comparable data are there for Laos and Libya?
- 18 years are reported by both, from 2000 to 2023.
- How do Laos and Libya rank globally for antiretroviral therapy coverage for pmtct?
- Laos ranks 54th and Libya ranks 51st of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).